Connexin Therapeutics Revenue

Biotechnology Research • Cambridge, England, United Kingdom • 1-10 Employees

Connexin Therapeutics revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Connexin Therapeutics

Carlos N. Velez

Chief Executive Officer

Company overview

Headquarters	23 King Street, 209, Cambridge, CB1 1AH, GB
Phone number	+442086388329
Website	connexintx.co.uk
NAICS	541714
Keywords	Biotechnology, Pharmaceuticals, Ophthalmology, Drug Discovery, Seed
Employees	1-10
Socials

About Connexin Therapeutics

Connexin Therapeutics is developing small molecule drugs which protect and preserve vision in glaucoma, retinopathies, and various corneal conditions. We are raising our Seed Round of £10 million to advance our programs into IND.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Connexin Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Connexin Therapeutics has never raised funding before.

Connexin Therapeutics Tech Stack

Discover the technologies and tools that power Connexin Therapeutics's digital infrastructure, from frameworks to analytics platforms.

AOS

JavaScript libraries

Google Workspace

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

Google Hosted Libraries

CDN

jQuery

JavaScript libraries

Contact Form 7

Form builders

PHP

Programming languages

WordPress

Blogs

core-js

JavaScript libraries

RSS

Miscellaneous

MySQL

Databases

Frequently asked questions

Connexin Therapeutics is located in Cambridge, England, GB.

You can reach Connexin Therapeutics at +442086388329.

Connexin Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Connexin Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Connexin Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Connexin Therapeutics

Carlos N. Velez

Chief Executive Officer

4.8

40,000 users